Skip to content

A novel edge AI-enabled microfluidic biosensor for intelligent, real-time, and autonomous IoT monitoring

Aug 2026 · Microfluidics and Nanofluidics · Vol 30 · 0 citations · 53 references

TL;DR

The feasibility of integrating Edge AI with microfluidic biosensing concepts for low-latency and energy-aware monitoring of critical biomarkers is demonstrated and full analytical and device-level validation remains future work.

View source

Similar papers

Review Open access Jul 2026

AI-Powered Wearable Devices for Real-Time Health Monitoring: Technologies, Challenges, and Emerging Trends

This work connects biomedical signal capture, on-device AI, clinical translation, and digital ethics to delineate a roadmap for frontier AI wearables, and proposed edge-aware transformer-based models, privacy-preserving analytics, and global multimodal sensing advance intelligent, scalable, and fair AI-driven health mo...

B. Bali, Favanza Iliya Kwaha · 0 citations
Conference Aug 2026

Edge-AI Assisted MXene-Based Fiber Optic IoT Biosensor Framework for Intelligent Wearable Healthcare Electronics

Wearable healthcare electronics have become widespread and rapid advancement of this technology has pushed for intelligent, real-time and non-invasive biosensing technologies. The traditional wearable sensors are generally low in sensitivity, susceptible to electromagnetic interference, and consume too much energy, whi...

Linto M George, P. George, Princy Sera Rajan et al. · 0 citations
Review Open access Aug 2026

Recent advances in smart nanosensors and IoT-based systems for real-time diagnostic monitoring.

The main findings reveal that nanosensor-enabled systems can significantly enhance diagnostic performance, with graphene-based nanosensors detecting C-reactive protein in human serum at concentrations near 27 pM, and plasmonic sensors offering swift, portable detection.

B. O. Omiyale, Akinola Ogbeyemi, Jethro Odeyemi et al. · 0 citations
Review Open access Aug 2026

Intelligent medical sensors for smart healthcare and precision medicine.

Clinical translation remains limited by data security and privacy risks, insufficient standardization and regulatory alignment, long-term stability and biocompatibility concerns, and uneven validation maturity across technologies.

Ji-Rui Wen, Jiang Wu, Yi Yang et al. · 0 citations
Review Open access Aug 2026

Artificial Intelligence in Biosensor Systems for Healthcare: From Molecular Recognition to Machine Learning

By linking molecular-level recognition with computational signal interpretation, this review highlights the advantages and limitations of artificial intelligence-integrated biosensors for next-generation point-of-care diagnostics, continuous health monitoring, and personalized healthcare applications.

Ö. Altıntaş, Adil Denizli · 0 citations
Review Open access Jul 2026

Smart wearable biosensors: a transformative synergy between diagnosis and treatment of disease

This review provides a critical chemistry-to-clinical perspective on smart wearable biosensors and outlines the validation, manufacturing, cybersecurity, post-market surveillance and benchmarking requirements needed for their translation into reliable diagnostic and therapeutic-monitoring technologies.

Yachana Misha, Radheshyam Jena, Aman Shukla et al. · 0 citations

Related blog posts

Microsoft Research Blog Oct 6, 2026

What AI gets wrong and what failure teaches us

Jennifer Neville did not want to go into computer science—but that’s exactly where she landed. Neville discusses the starts and stops that led to her professional sweet spot and her work identifying “surprising failures” making it hard for AI to handle complexity.  The post What AI gets wrong and what failure teaches us appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.